Repeated delivery of chlorhexidine chips for the treatment of peri‐implantitis: A multicenter, randomized, comparative clinical trial
Machtei, Eli E.; Romanos, Georgios; Kang, Philip; Travan, Suncica; Schmidt, Stephan; Papathanasiou, Evangelos; Tatarakis, Nikolaos; Tandlich, Moshik; Liberman, Leila H.; Horwitz, Jacob; Bassir, Seyed Hossein; Myneni, Srinivas; Shiau, Harlan J.; Shapira, Lior; Donos, Nikos; Papas, Athena; Meyle, Joerg; Giannobile, William V.; Papapanou, Panos N.; Kim, David M.
2021-01
Citation
Machtei, Eli E.; Romanos, Georgios; Kang, Philip; Travan, Suncica; Schmidt, Stephan; Papathanasiou, Evangelos; Tatarakis, Nikolaos; Tandlich, Moshik; Liberman, Leila H.; Horwitz, Jacob; Bassir, Seyed Hossein; Myneni, Srinivas; Shiau, Harlan J.; Shapira, Lior; Donos, Nikos; Papas, Athena; Meyle, Joerg; Giannobile, William V.; Papapanou, Panos N.; Kim, David M. (2021). "Repeated delivery of chlorhexidine chips for the treatment of peri‐implantitis: A multicenter, randomized, comparative clinical trial." Journal of Periodontology 92(1): 11-20.
Abstract
BackgroundPeri‐implantitis is a challenging condition to manage and is frequently treated using non‐surgical debridement. The local delivery of antimicrobial agents has demonstrated benefit in mild to moderate cases of peri‐implantitis. This study compared the safety and efficacy of chlorhexidine gluconate 2.5 mg chip (CHX chips) as an adjunctive treatment to subgingival debridement in patients afflicted with peri‐implantitis.MethodsA multicenter, randomized, single‐blind, two‐arm, parallel Phase‐3 study was conducted. Peri‐implantitis patients with implant pocket depths (IPD) of 5‐8 mm underwent subgingival implant surface debridement followed by repeated bi‐weekly supragingival plaque removal and chlorhexidine chips application (ChxC group) for 12 weeks, or similar therapy but without application of ChxC (control group). All patients were followed for 24 weeks. Plaque and gingival indices were measured at every visit whereas IPD, recession, and bleeding on probing were assessed at 8, 12, 16, 24 week.ResultsA total of 290 patients were included: 146 in the ChxC group and 144 in the control. At 24 weeks, a significant reduction in IPD (P = 0.01) was measured in the ChxC group (1.76 ± 1.13 mm) compared with the control group (1.54 ± 1.13 mm). IPD reduction of ≥2 mm was found in 59% and 47.2% of the implants in the ChxC and control groups, respectively (P = 0.03). Changes in gingival recession (0.29 ± 0.68 mm versus 0.15 ± 0.55 mm, P = 0.015) and relative attachment gain (1.47 ± 1.32 mm and 1.39 ± 1.27 mm, P = 0.0017) were significantly larger in the ChxC group. Patients in the ChxC group that were < 65 years exhibited significantly better responses (P < 0.02); likewise, non‐smokers had similarly better response (P < 0.02). Both protocols were well tolerated, and no severe treatment‐related adverse events were recorded throughout the study.ConclusionsPatients with peri‐implantitis that were treated with an intensive treatment protocol of bi‐weekly supragingival plaque removal and local application of chlorhexidine chips had greater mean IPD reduction and greater percentile of sites with IPD reduction of ≥2 mm as compared with bi‐weekly supra‐gingival plaque removal.Publisher
Wiley Periodicals, Inc.
ISSN
0022-3492 1943-3670
Deep Blue DOI
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.